Drug Profile
Omidenepag isopropyl - Santen Pharmaceutical/Ube Industries
Alternative Names: DE-117; EYBELIS; OMLONTI; STN-1011700; STN10117Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Ube Industries
- Developer Santen Pharmaceutical; Ube Industries
- Class Antiglaucomas; Pyrazoles; Pyridines; Small molecules; Sulfonamides
- Mechanism of Action Prostaglandin E EP2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Glaucoma; Ocular hypertension